01 5Aspen Pharmacare Holdings
02 7Strides Pharma Science
03 1Adcock Ingram
04 1Aeon Formulations Private Limited
05 8Aurobindo Pharma Limited
06 6Bristol Laboratories Ltd
07 23Bristol Myers Squibb
08 5Cipla
09 2Cipla Medpro South Africa
10 3Emcure Pharmaceuticals
11 6Hetero Drugs
12 1LeBasi Pharmaceuticals CC
13 5Macleods Pharmaceuticals Limited
14 2Modern Laboratories
15 6NORVIUM BIOSCIENCE
16 4Orbit Lifescience
17 4Pharmacare Premium
18 1Sanjivani Paranteral
19 1Smith & Kenner Pharmaceuticals
20 2Sun Pharmaceutical Industries Limited
21 4Varichem Pharmaceuticals Pvt Ltd
22 2Viatris
01 14CAP
02 7CAPSULE
03 4CAPSULE, EXTENDED RELEASE;ORAL
04 3CAPSULE; ORAL
05 19CAPSULE;ORAL
06 6Capsule
07 3Capsule, hard
08 1FILM COATED TABLET
09 3FOR SOLUTION;ORAL
10 4HARD CAPSULES
11 1Oral Solution
12 1POWDER FOR ORAL SOLUTION
13 1SOL
14 1SUS
15 1Stavudine 1Mg/Ml 200Ml Oral Use
16 1Stavudine 20Mg 56 Combined Oral Use
17 1Stavudine 30Mg 56 Combined Oral Use
18 1Stavudine 40Mg 56 Combined Oral Use
19 5TAB
20 1TABLET
21 18TABLET; ORAL
22 3Tablet
01 26DISCN
02 21Generic
03 4Generic WHO/SRA/ERP Approved
04 5Originator
05 43Blank
01 3Aspen Stavudine
02 1Aspen Stavudine 30 mg
03 1Auro-Stavudine Powder For Oral Solution 1 mg/ml
04 1LAMITEC-S
05 2LAMIVUDINE AND STAVUDINE
06 1LAMIVUDINE, NEVIRAPINE, AND STAVUDINE
07 4LAMIVUDINE; STAVUDINE
08 1STAVIEON-L
09 19STAVUDINE
10 1STAVUDINE 30 MG CAPS
11 1STAVUDINE ORAL SOLUTION
12 3STAVUDINE; LAMIVUDINE
13 1STAVUDINE; LAMIVUDINE W/NEVIRAPINE
14 1STAVUDINE; LAMIVUDINE; EFAVIRENZ
15 6STAVUDINE; LAMIVUDINE; NEVIRAPINE
16 1Sonke-Laminevstav 30
17 1Sonke-Stavudine 30
18 1Stalanev 30
19 1Stalanev 40
20 1Stavir-30
21 1Stavir-40
22 1Tri-Nestlam 150/30/200
23 1Triomune 30
24 1Triomune 40
25 1VIROZEN-S
26 1Vanra 30 mg Caspules
27 1Vanra 40 mg Capsules
28 1Vari-Stavudine 30mg
29 1Virtrium 30/150/200
30 6ZERIT
31 4ZERIT XR
32 18Zerit
33 1Zerit powder for oral Solution
34 10Blank
01 9India
02 4Italy
03 5Norway
04 21South Africa
05 5Sweden
06 47USA
07 4United Kingdom
08 4Zimbabwe
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Aspen Stavudine
Dosage Form : CAP
Dosage Strength : 20mg
Packaging : 60X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Regulatory Info :
Registration Country : USA
STAVUDINE; LAMIVUDINE; NEVIRAPINE
Brand Name : STAVUDINE; LAMIVUDINE; NEVIRAPINE
Dosage Form : TABLET; ORAL
Dosage Strength : 40MG; 150MG; 200MG
Packaging :
Approval Date :
Application Number : 21837
Regulatory Info :
Registration Country : USA
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Aspen Stavudine 30 mg
Dosage Form : CAP
Dosage Strength : 30mg
Packaging : 60X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Aspen Stavudine
Dosage Form : CAP
Dosage Strength : 40mg
Packaging : 60X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Aspen Stavudine
Dosage Form : CAP
Dosage Strength : 15mg
Packaging : 60X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Virtrium 30/150/200
Dosage Form : TAB
Dosage Strength : 30mg
Packaging : 60X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Regulatory Info :
Registration Country : USA
Brand Name : STAVUDINE; LAMIVUDINE
Dosage Form : TABLET; ORAL
Dosage Strength : 40MG; 150MG
Packaging :
Approval Date :
Application Number : 21838
Regulatory Info :
Registration Country : USA
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Regulatory Info :
Registration Country : USA
STAVUDINE; LAMIVUDINE; NEVIRAPINE
Brand Name : STAVUDINE; LAMIVUDINE W/NEVIRAPINE
Dosage Form : TABLET; ORAL
Dosage Strength : 40MG; 150MG; 200MG
Packaging :
Approval Date :
Application Number : 21854
Regulatory Info :
Registration Country : USA
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Regulatory Info :
Registration Country : USA
STAVUDINE; LAMIVUDINE; EFAVIRENZ
Brand Name : STAVUDINE; LAMIVUDINE; EFAVIRENZ
Dosage Form : TABLET; ORAL
Dosage Strength : 40MG; 150MG; 600MG
Packaging :
Approval Date :
Application Number : 22097
Regulatory Info :
Registration Country : USA
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Regulatory Info :
Registration Country : USA
STAVUDINE; LAMIVUDINE; NEVIRAPINE
Brand Name : STAVUDINE; LAMIVUDINE; NEVIRAPINE
Dosage Form : TABLET; ORAL
Dosage Strength : 30MG; 150MG; 200MG
Packaging :
Approval Date :
Application Number : 22177
Regulatory Info :
Registration Country : USA
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Regulatory Info :
Registration Country : USA
Brand Name : STAVUDINE
Dosage Form : CAPSULE; ORAL
Dosage Strength : 30MG
Packaging :
Approval Date :
Application Number : 78256
Regulatory Info :
Registration Country : USA
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Regulatory Info :
Registration Country : USA
Brand Name : STAVUDINE
Dosage Form : CAPSULE; ORAL
Dosage Strength : 40MG
Packaging :
Approval Date :
Application Number : 78256
Regulatory Info :
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ZERIT
Dosage Form : CAPSULE;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 1994-06-24
Application Number : 20412
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ZERIT
Dosage Form : CAPSULE;ORAL
Dosage Strength : 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1994-06-24
Application Number : 20412
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ZERIT
Dosage Form : CAPSULE;ORAL
Dosage Strength : 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1994-06-24
Application Number : 20412
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ZERIT
Dosage Form : CAPSULE;ORAL
Dosage Strength : 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1994-06-24
Application Number : 20412
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ZERIT
Dosage Form : CAPSULE;ORAL
Dosage Strength : 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1994-06-24
Application Number : 20412
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ZERIT
Dosage Form : FOR SOLUTION;ORAL
Dosage Strength : 1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1996-09-06
Application Number : 20413
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ZERIT XR
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 37.5MG
Packaging :
Approval Date : 2002-12-31
Application Number : 21453
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ZERIT XR
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 2002-12-31
Application Number : 21453
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ZERIT XR
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 75MG
Packaging :
Approval Date : 2002-12-31
Application Number : 21453
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ZERIT XR
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date : 2002-12-31
Application Number : 21453
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : LAMIVUDINE; STAVUDINE
Dosage Form : TABLET; ORAL
Dosage Strength : 150MG; 30MG
Packaging :
Approval Date :
Application Number : 21974
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : LAMIVUDINE; STAVUDINE
Dosage Form : TABLET; ORAL
Dosage Strength : 150MG; 40MG
Packaging :
Approval Date :
Application Number : 21974
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
STAVUDINE; LAMIVUDINE; NEVIRAPINE
Brand Name : STAVUDINE; LAMIVUDINE; NEVIRAPINE
Dosage Form : TABLET; ORAL
Dosage Strength : 30MG; 150MG; 200MG
Packaging :
Approval Date :
Application Number : 22342
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
STAVUDINE; LAMIVUDINE; NEVIRAPINE
Brand Name : STAVUDINE; LAMIVUDINE; NEVIRAPINE
Dosage Form : TABLET; ORAL
Dosage Strength : 40MG; 150MG; 200MG
Packaging :
Approval Date :
Application Number : 22342
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
STAVUDINE; LAMIVUDINE; NEVIRAPINE
Brand Name : STAVUDINE; LAMIVUDINE; NEVIRAPINE
Dosage Form : TABLET; ORAL
Dosage Strength : 30MG; 150MG; 200MG
Packaging :
Approval Date :
Application Number : 22346
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
STAVUDINE; LAMIVUDINE; NEVIRAPINE
Brand Name : STAVUDINE; LAMIVUDINE; NEVIRAPINE
Dosage Form : TABLET; ORAL
Dosage Strength : 40MG; 150MG; 200MG
Packaging :
Approval Date :
Application Number : 22346
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : LAMIVUDINE; STAVUDINE
Dosage Form : TABLET; ORAL
Dosage Strength : 150MG; 30MG
Packaging :
Approval Date :
Application Number : 22085
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : LAMIVUDINE; STAVUDINE
Dosage Form : TABLET; ORAL
Dosage Strength : 150MG; 40MG
Packaging :
Approval Date :
Application Number : 22085
Regulatory Info :
Registration Country : USA
